A Study of LY3381916 Alone or in Combination With LY3300054 in Participants With Solid Tumors

Clinical trial NCT03343613 · TERMINATED

Trial details

NCT number: NCT03343613
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Non Small Cell Lung Cancer Renal Cell Carcinoma Triple Negative Breast Cancer

Start date: 2017-11-17
Primary completion: 2020-02-07
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.